You Searched For "weight loss drugs" and got 20 results
Sort By:
The next big market for weight-loss drugs: children
Novo Nordisk's weight loss drug, Saxenda, helped children ages six to 11 reduce their body mass ind…
Shubhangi Goel
Weight-loss drugs like Ozempic could help slow biological aging, researchers say
Physicians warn that weight-loss drugs such as Ozempic and Wegovy come with a risk of severe side e…
Rebecca Rommen
Eli Lilly's weight-loss drug may prevent diabetes — but there's 1 unanswered question
People with pre-diabetes who took Zepbound or Mounjaro were 94% less likely to develop the disease,…
Hilary Brueck
Forget keto — Ozempic might finally kill the low-carb diet trend
The booming market for GLP-1 medications like Ozempic that aid weight loss may be prompting a nosed…
Gabby Landsverk
Eli Lilly just halved the price of its weight-loss drug — declaring war on the booming market of knock-offs
Eli Lilly is now offering cheaper single-dose vials of its wildly popular weight-loss drug Zepbound…
Gabby Landsverk
Weight loss and diabetes drug Tirzepatide will cost Rs 80,000 per month in India
Tirzepatide is set to make its debut in the Indian market under the brand name Mounjaro for the tre…
'Unbelievable demand' for weight-loss drugs sends Eli Lilly stock soaring 14% after earnings
"We just see unbelievable demand, and we're not even trying that hard to promote this drug. We're n…
Matthew Fox
A man rapidly lost weight on a popular weight-loss drug. After 6 months, he was hospitalized with heart problems and confusion.
A man lost more than 80 pounds in six months on popular weight drug tirzepatide. He hadn't adjusted…
Gabby Landsverk
The FDA says patients may be overdosing on imitation semaglutide weight-loss drugs because the directions are unclear
The FDA warned that incorrect dosing of compounded semaglutide products may be causing health prob…
Lauren Edmonds
Scientists say weight-loss drugs could protect our brains from dementia. Early results suggest they're onto something.
Patients with Alzheimer's who took a GLP-1 drug improved their memory scores and lost less of their…
Hilary Brueck
Hims & Hers is getting into the weight-loss drug game and Wall Street is loving it
Hims & Hers compounded GLP-1 — the same ingredient as Ozempic — will be priced at $200 …
Geoff Weiss
Top doctor warns against taking weight loss drugs such as Ozempic to get 'beach body ready' for summer
The active ingredient in Ozempic, semaglutide, mimics GLP-1, a hormone that makes you feel full.
Nathan Rennolds
The newest weight-loss hack has people turning to a highly addictive drug
A new weight-loss quick fix is making the rounds just in time for summer's unofficial start, but th…
Dan DeFrancesco
Moms say their weight-loss drugs had a trickle-down effect — making their entire families healthier
Some people on weight-loss drugs say their treatment is lifting up the health of their entire famil…
Emily Farache
Bernie Sanders to grill Novo Nordisk CEO on why weight-loss drugs Ozempic and Wegovy can cost up to 15 times more in US
Lars Jørgensen will testify on a solo panel before the Senate Committee on Health, Education, Labor…
Nathan Rennolds
Viking Therapeutics skyrockets 25% on positive results for experimental weight loss drug
Weight-loss drugs like Ozempic have fueled a rally in pharmaceutical stocks in 2024, as investors e…
Yuheng Zhan
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030, Goldman Sachs says
The anti-obesity drug market will be worth $130 billion by 2030, Goldman Sachs analysts said in a r…
George Glover
Another perk of weight-loss drugs? Eli Lilly's Zepbound may alleviate sleep apnea, too
The new class of weight-loss drugs isn't just for diabetes and weight loss. Eli Lilly results from …
Hilary Brueck
Amgen soars 16% after it talks up a new weight loss drug that could be injected monthly instead of weekly
Goldman Sachs said Amgen's experimental GLP-1 drug could have peak sales of $5 billion, or 5% of th…
Matthew Fox
Blockbuster weight-loss drug Wegovy's sales just doubled and could heat up even more with a price cut
Sales of Wegovy more than doubled in the first quarter year on year to $1.3 billion.